BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38162066)

  • 1. [
    Ou Q; Chen Z; Tang J; Chen M; Zhang Y; Wang C
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Nov; 54(6):1159-1166. PubMed ID: 38162066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Listeria ivanovii balanced-lethal system may be a promising antigen carrier for vaccine construction.
    Lei Y; Zhou Y; Zhang Y; Liu S; Tian S; Ou Q; Liu T; Huang H; Tang T; Wang C
    Microb Biotechnol; 2022 Nov; 15(11):2831-2844. PubMed ID: 36069650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination immunotherapy with two attenuated Listeria strains carrying shuffled HPV-16 E6E7 protein causes tumor regression in a mouse tumor model.
    Su L; Zhang Y; Zhang X; Liu T; Liu S; Li Y; Jiang M; Tang T; Shen H; Wang C
    Sci Rep; 2021 Jun; 11(1):13404. PubMed ID: 34183739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction and characterization of an attenuated Listeria monocytogenes strain for clinical use in cancer immunotherapy.
    Wallecha A; Maciag PC; Rivera S; Paterson Y; Shahabi V
    Clin Vaccine Immunol; 2009 Jan; 16(1):96-103. PubMed ID: 19020110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Genetic Recombiniation and Protein Expression Detection of
    Ren CY; Liu SJ; Pu QK; Jiang MJ; Zhou MY; Wang C
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Nov; 47(6):819-824. PubMed ID: 28598105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Construction and Evaluation of a Tuberculosis Multistage Vaccine Candidate Based on Recombinant
    Liu T; Liu SJ; Zhou YZ; Zhang YW; Wang C
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 Jan; 51(1):1-6. PubMed ID: 31950781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenicity and immunogenicity of a vaccine strain of Listeria monocytogenes that relies on a suicide plasmid to supply an essential gene product.
    Zhao X; Li Z; Gu B; Frankel FR
    Infect Immun; 2005 Sep; 73(9):5789-98. PubMed ID: 16113297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Genetically Modified attenuated
    Jia YY; Tan WJ; Duan FF; Pan ZM; Chen X; Yin YL; Jiao XA
    Front Cell Infect Microbiol; 2017; 7():279. PubMed ID: 28706878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Construction and Evaluation of a Novel TB Vaccine Candidate Based on
    Huang JL; Liu SJ; Su L; Wang C
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Nov; 48(6):814-818. PubMed ID: 29260512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stable integration vector for nutrient broth-based selection of attenuated Listeria monocytogenes strains with recombinant antigen expression.
    Lenz LL; Huang WA; Zhou C; Li Z; Calendar R
    Clin Vaccine Immunol; 2008 Sep; 15(9):1414-9. PubMed ID: 18650400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant
    Liang Q; Li R; Liu S; Zhang Y; Tian S; Ou Q; Chen Z; Wang C
    Front Microbiol; 2022; 13():962326. PubMed ID: 35935244
    [No Abstract]   [Full Text] [Related]  

  • 12. [Construction and Fluorescence Analysis of the Recombinant
    Zhang X; Su L; Liu SJ; Li YY; Jiang MJ; Huang H; Wang C
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Nov; 48(6):809-813. PubMed ID: 29260511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction of two Listeria ivanovii attenuated strains expressing Mycobacterium tuberculosis antigens for TB vaccine purposes.
    Lin Q; Zhou M; Xu Z; Khanniche A; Shen H; Wang C
    J Biotechnol; 2015 Feb; 196-197():20-6. PubMed ID: 25612873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Construction and characterization of Listeria monocytogenes deltaprfA mutant strains].
    Bai C; Yin Y; Jia Y; Fu H; Gao Y; Jiao X
    Wei Sheng Wu Xue Bao; 2011 Nov; 51(11):1555-60. PubMed ID: 22260054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuated
    Zeng H; Xie M; Ding C; Ma J; Xu D; Wang X; Qiu J; Liu Q
    Front Microbiol; 2020; 11():70. PubMed ID: 32153514
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibitory effect of live-attenuated Listeria monocytogenes-based vaccines expressing MIA gene on malignant melanoma.
    Qian Y; Zhang N; Jiang P; Chen S; Chu S; Hamze F; Wu Y; Luo Q; Feng A
    J Huazhong Univ Sci Technolog Med Sci; 2012 Aug; 32(4):591-597. PubMed ID: 22886976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuated Listeria monocytogenes: a powerful and versatile vector for the future of tumor immunotherapy.
    Wood LM; Paterson Y
    Front Cell Infect Microbiol; 2014; 4():51. PubMed ID: 24860789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Construction and characterization of an attenuated recombinant Listeria monocytogenes vector vaccine delivering HPV16 E7].
    Jia Y; Yin Y; Tan W; Duan F; Pan Z; Chen X; Jiao XA
    Sheng Wu Gong Cheng Xue Bao; 2016 May; 32(5):683-692. PubMed ID: 29019205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression plasmid-host strain using chromosome-plasmid balanced lethal system based on the Escherichia coli thyA].
    Huang W; Cao C; Li P; Zhong H; Ma QJ
    Sheng Wu Gong Cheng Xue Bao; 2003 Sep; 19(5):521-6. PubMed ID: 15969077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Listeria monocytogenes-based antibiotic resistance gene-free antigen delivery system applicable to other bacterial vectors and DNA vaccines.
    Verch T; Pan ZK; Paterson Y
    Infect Immun; 2004 Nov; 72(11):6418-25. PubMed ID: 15501772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.